View in EDS HTML Full Text PDF Full Text

Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.

Saved in:
Bibliographic Details
Title: Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.
Authors: Watts J; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Minden MD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada., Bachiashvili K; Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Brunner AM; Leukemia Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Abedin S; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Crossman T; Oncology Clinical Development, GSK, Gunnels Wood Road, Stevenage, Herts SG1 2NY, UK., Zajac M; Oncology Clinical Development, GSK, London, UK., Moroz V; Biostatistics, GSK, Stevenage, UK., Egger JL; Oncology Clinical Development, GSK, London, UK., Tarkar A; Oncology Clinical Development, GSK, Collegeville, PA, USA., Kremer BE; Oncology Clinical Development, GSK, Collegeville, PA, USA., Barbash O; Oncology Clinical Development, GSK, Collegeville, PA, USA., Borthakur G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2024 Sep 14; Vol. 15, pp. 20406207241275376. Date of Electronic Publication: 2024 Sep 14 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39290981
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Watts+J%22">Watts J</searchLink>; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Minden+MD%22">Minden MD</searchLink>; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Bachiashvili+K%22">Bachiashvili K</searchLink>; Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Brunner+AM%22">Brunner AM</searchLink>; Leukemia Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abedin+S%22">Abedin S</searchLink>; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Crossman+T%22">Crossman T</searchLink>; Oncology Clinical Development, GSK, Gunnels Wood Road, Stevenage, Herts SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Zajac+M%22">Zajac M</searchLink>; Oncology Clinical Development, GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Moroz+V%22">Moroz V</searchLink>; Biostatistics, GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Egger+JL%22">Egger JL</searchLink>; Oncology Clinical Development, GSK, London, UK.<br /><searchLink fieldCode="AU" term="%22Tarkar+A%22">Tarkar A</searchLink>; Oncology Clinical Development, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kremer+BE%22">Kremer BE</searchLink>; Oncology Clinical Development, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Oncology Clinical Development, GSK, Collegeville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Borthakur+G%22">Borthakur G</searchLink>; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2024 Sep 14; Vol. 15, pp. 20406207241275376. <i>Date of Electronic Publication: </i>2024 Sep 14 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39290981
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/20406207241275376
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20406207241275376
    Titles:
      – TitleFull: Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Watts J
      – PersonEntity:
          Name:
            NameFull: Minden MD
      – PersonEntity:
          Name:
            NameFull: Bachiashvili K
      – PersonEntity:
          Name:
            NameFull: Brunner AM
      – PersonEntity:
          Name:
            NameFull: Abedin S
      – PersonEntity:
          Name:
            NameFull: Crossman T
      – PersonEntity:
          Name:
            NameFull: Zajac M
      – PersonEntity:
          Name:
            NameFull: Moroz V
      – PersonEntity:
          Name:
            NameFull: Egger JL
      – PersonEntity:
          Name:
            NameFull: Tarkar A
      – PersonEntity:
          Name:
            NameFull: Kremer BE
      – PersonEntity:
          Name:
            NameFull: Barbash O
      – PersonEntity:
          Name:
            NameFull: Borthakur G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 09
              Text: 2024 Sep 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2040-6207
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Therapeutic advances in hematology
              Type: main
ResultId 1